Hrmy earnings
WebHarmony Biosciences Holdings (HRMY) will release its next earnings report on May 9, 2024. In the last quarter Harmony Biosciences Holdings reported $0.584 EPS in relation to $0.79 expected by the market. WebOverview Forecast Earnings Dividend Ownership Analyst price target for HRMY All Analysts Top Analysts Based on 6 analyst s offering 12 month price targets for Harmony Biosciences Holdings Inc. Min Forecast $43.00 +40.98% Avg Forecast $60.50 +98.36% Max Forecast $70.00 +129.51% Should I buy or sell HRMY stock? All Analysts Top …
Hrmy earnings
Did you know?
WebUpgrade to Premium to see how . HRMY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks. Try It for Just $1. ... HRMY price to earnings (PE)For valuing profitable companies with steady earnings. Company. 10.87x. Industry. 18.17x. Market. 21.81x. WebHarmony Biosciences Holdings (HRMY) will release its next earnings report on May 9, 2024. In the last quarter Harmony Biosciences Holdings reported $0.584 EPS in relation …
Web31 mrt. 2024 · HRMY Harmony Biosciences Holdings, Inc.Earnings Call Transcripts. 1.49K followers. $32.65 -0.03 ( -0.09%) 4:00 PM 03/31/23. NASDAQ $USD Post-Market: … Web1 dag geleden · Earnings Summary For their last quarter, Harmony Biosciences (HRMY) reported earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.54 per share. This reflects a positive...
WebHRMY: Harmony Biosciences Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. HRMY: Harmony Biosciences - Detailed Earnings … WebThe one-year underlying earnings growth at Harmony Biosciences Holdings (NASDAQ:HRMY) is promising, but the shareholders are still in the red over that time …
Web1 nov. 2024 · November 1, 2024, 8:55 AM · 4 min read Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.95 per share, beating the Zacks …
Web31 mrt. 2024 · Is Harmony Biosciences (NASDAQ:HRMY) the best stock in the Pharmaceutical preparations industry? Compare top HRMY competitors at MarketBeat. Skip to main content. S&P 500 (+1.33%) DOW (+1.14%) ... institutional ownership, community ranking, earnings, media sentiment, analyst recommendations, risk, dividends and … christoph fluriWebPrice to earnings Ratio (TTM) 10.46 Basic EPS (TTM) 3.06 USD About Harmony Biosciences Holdings, Inc ISIN US4131971040 Sector Health Technology Industry Pharmaceuticals: Major Website harmonybiosciences.com CEO Jeffrey M. Dayno Headquarters Plymouth Meeting Employees 200 Founded 2024 christoph forthuberWebFind the latest Earnings Report Date for Harmony Biosciences Holdings, Inc. Common Stock (HRMY) at Nasdaq.com. Harmony Biosciences Holdings, Inc. Common Stock … gfhfx aircraftWeb29 mrt. 2024 · Harmony Biosciences Holdings Inc. analyst ratings, historical stock prices, earnings estimates & actuals. HRMY updated stock price target summary. Dow Jones, a … christoph forster hamburgWeb21 feb. 2024 · Full Year 2024 Financial Results. Net product revenues for the year ended December 31, 2024 were $437.9 million, compared to $305.4 million for 2024. The … christoph forster architektWeb29 mrt. 2024 · HRMY Harmony Biosciences Holdings Inc. Analyst Estimates & Rating – WSJ Harmony Biosciences Holdings Inc. HRMY (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 03/29/23 $33.36 USD... christoph fortmann vechtaWeb2 apr. 2024 · Earnings for Harmony Biosciences are expected to grow by 55.23% in the coming year, from $2.39 to $3.71 per share. Harmony Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date … christoph forsting